Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT06055075 |
| Title | A Study Evaluating Safety, Tolerability, and Clinical Activity of Forimtamig-Based Treatment Combinations in Participants With Relapsed or Refractory Multiple Myeloma |
| Recruitment | Active, not recruiting |
| Gender | both |
| Phase | Phase I |
| Variant Requirements | No |
| Sponsors | Hoffmann-La Roche |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | NZL | ITA | ESP | CAN | AUS |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Princess Alexandra Hospital Woolloongabba | Woolloongabba | Queensland | 4102 | Australia | Details | |
| Royal Adelaide Hospital | Adelaide | South Australia | 5000 | Australia | Details | |
| Hamilton Health Sciences | Hamilton | Ontario | L8V 5C2 | Canada | Details | |
| Istituto Clinico Humanitas | Rozzano | Lombardia | 20089 | Italy | Details | |
| Seoul National University Hospital | Seoul | 03080 | Korea, Republic of | Details | ||
| Seoul St Mary's Hospital | Seoul | 06591 | Korea, Republic of | Details | ||
| New Zealand Clinical Research - Auckland | Auckland | 1010 | New Zealand | Details | ||
| Clinica Universitaria de Navarra | Pamplona | Navarra | 31008 | Spain | Details |